ICG-001
| CAS No. | 780757-88-2 | Cat. No. | BCP13217 |
| Name | ICG-001 | ||
| Synonyms | ICG 001;ICG001; | ||
| Formula | C33H32N4O4 | M. Wt | 548.64 |
| Description | After treatment with 25μM of ICG-001 for 8 hours, SW480 cell reduces the steady-state levels of Survivin and Cyclin D1 RNA and protein, both of which can be up-regulated by β-catenin. ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells. ICG-001, can phenotypically rescue normal nerve growth factor (NGF) -induced neuronal differentiation and neurite outgrowth in the presenilin-1 mutant cells, emphasizing the importance of the TCF/β-catenin signaling pathway on neurite outgrowth and neuronal differentiation. A recent study demonstrates that 5μM ICG-001 inhibits leptin-induced EMT, invasion and tumorsphere formation in MCF7 cells. | ||
| Related Products | 1422253-38-0（PRI-724） 847591-62-2（ICG-001） | ||
| Pathways | Wnt/Stem Cell | ||
| Targets | Wnt | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.